412 related articles for article (PubMed ID: 33592059)
1. Genomic and RT-qPCR analysis of trimethoprim-sulfamethoxazole and meropenem resistance in Burkholderia pseudomallei clinical isolates.
Schnetterle M; Gorgé O; Nolent F; Boughammoura A; Sarilar V; Vigier C; Guillier S; Koch L; Degand N; Ramisse V; Tichadou X; Girleanu M; Favier AL; Valade E; Biot F; Neulat-Ripoll F
PLoS Negl Trop Dis; 2021 Feb; 15(2):e0008913. PubMed ID: 33592059
[TBL] [Abstract][Full Text] [Related]
2. Raising the Stakes: Loss of Efflux Pump Regulation Decreases Meropenem Susceptibility in Burkholderia pseudomallei.
Sarovich DS; Webb JR; Pitman MC; Viberg LT; Mayo M; Baird RW; Robson JM; Currie BJ; Price EP
Clin Infect Dis; 2018 Jul; 67(2):243-250. PubMed ID: 29394337
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of Resistance to Folate Pathway Inhibitors in
Podnecky NL; Rhodes KA; Mima T; Drew HR; Chirakul S; Wuthiekanun V; Schupp JM; Sarovich DS; Currie BJ; Keim P; Schweizer HP
mBio; 2017 Sep; 8(5):. PubMed ID: 28874476
[TBL] [Abstract][Full Text] [Related]
4. Current antimicrobial susceptibility of first-episode melioidosis Burkholderia pseudomallei isolates from the Northern Territory, Australia.
Crowe A; McMahon N; Currie BJ; Baird RW
Int J Antimicrob Agents; 2014 Aug; 44(2):160-2. PubMed ID: 24924662
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a triplex quantitative real-time PCR assay to detect efflux pump-mediated antibiotic resistance in Burkholderia pseudomallei.
Webb JR; Price EP; Somprasong N; Schweizer HP; Baird RW; Currie BJ; Sarovich DS
Future Microbiol; 2018 Sep; 13(12):1403-1418. PubMed ID: 30256166
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic Resistance Markers in Burkholderia pseudomallei Strain Bp1651 Identified by Genome Sequence Analysis.
Bugrysheva JV; Sue D; Gee JE; Elrod MG; Hoffmaster AR; Randall LB; Chirakul S; Tuanyok A; Schweizer HP; Weigel LM
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28396541
[No Abstract] [Full Text] [Related]
7. Antimicrobial susceptibility and genetic characterisation of Burkholderia pseudomallei isolated from Malaysian patients.
Khosravi Y; Vellasamy KM; Mariappan V; Ng SL; Vadivelu J
ScientificWorldJournal; 2014; 2014():132971. PubMed ID: 25379514
[TBL] [Abstract][Full Text] [Related]
8. Epidemiological cut-off value of clinical isolates of Burkholderia pseudomallei from Northern Queensland to meropenem, ceftazidime, trimethoprim/sulfamethoxazole and doxycycline by the microbroth dilution method.
Maloney S; Engler C; Norton R
J Glob Antimicrob Resist; 2017 Sep; 10():291-294. PubMed ID: 28729203
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis.
Jenney AW; Lum G; Fisher DA; Currie BJ
Int J Antimicrob Agents; 2001 Feb; 17(2):109-13. PubMed ID: 11165114
[TBL] [Abstract][Full Text] [Related]
10. Cases of melioidosis in a university teaching hospital in Malaysia.
Raja NS
J Microbiol Immunol Infect; 2008 Apr; 41(2):174-9. PubMed ID: 18473106
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility of Burkholderia pseudomallei isolates in Northern Vietnam.
Nhung PH; Van VH; Anh NQ; Phuong DM
J Glob Antimicrob Resist; 2019 Sep; 18():34-36. PubMed ID: 30685463
[TBL] [Abstract][Full Text] [Related]
12. The BpeEF-OprC efflux pump is responsible for widespread trimethoprim resistance in clinical and environmental Burkholderia pseudomallei isolates.
Podnecky NL; Wuthiekanun V; Peacock SJ; Schweizer HP
Antimicrob Agents Chemother; 2013 Sep; 57(9):4381-6. PubMed ID: 23817379
[TBL] [Abstract][Full Text] [Related]
13. A comparative genomic analysis of small-colony variant and wild-type Burkholderia pseudomallei in a patient with bacterial liver abscess.
Wang X; Zheng X; Huang M; Liu L
J Glob Antimicrob Resist; 2020 Jun; 21():16-21. PubMed ID: 31562932
[TBL] [Abstract][Full Text] [Related]
14. Burkholderia pseudomallei: in vitro susceptibility to some new and old antimicrobials.
Karunakaran R; Puthucheary SD
Scand J Infect Dis; 2007; 39(10):858-61. PubMed ID: 17852912
[TBL] [Abstract][Full Text] [Related]
15. Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei from Thailand.
Saiprom N; Amornchai P; Wuthiekanun V; Day NP; Limmathurotsakul D; Peacock SJ; Chantratita N
Int J Antimicrob Agents; 2015 May; 45(5):557-9. PubMed ID: 25758020
[No Abstract] [Full Text] [Related]
16. Trimethoprim/sulfamethoxazole resistance in Burkholderia pseudomallei.
Dance DA; Davong V; Soeng S; Phetsouvanh R; Newton PN; Turner P
Int J Antimicrob Agents; 2014 Oct; 44(4):368-9. PubMed ID: 25245211
[No Abstract] [Full Text] [Related]
17. Mechanisms of antibiotic resistance in Burkholderia pseudomallei: implications for treatment of melioidosis.
Schweizer HP
Future Microbiol; 2012 Dec; 7(12):1389-99. PubMed ID: 23231488
[TBL] [Abstract][Full Text] [Related]
18. Melioidosis: misdiagnosed in Nepal.
Shrestha N; Adhikari M; Pant V; Baral S; Shrestha A; Basnyat B; Sharma S; Sherchand JB
BMC Infect Dis; 2019 Feb; 19(1):176. PubMed ID: 30782129
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial susceptibility patterns of Burkholderia pseudomallei among melioidosis cases in Kedah, Malaysia.
Hassan MR; Vijayalakshmi N; Pani SP; Peng NP; Mehenderkar R; Voralu K; Michael E
Southeast Asian J Trop Med Public Health; 2014 May; 45(3):680-8. PubMed ID: 24974653
[TBL] [Abstract][Full Text] [Related]
20. The antibiotics of choice for the treatment of melioidosis in Indian set up.
Shaw T; Tellapragada C; Eshwara VK; Bhat HV; Mukhopadhyay C
Indian J Med Microbiol; 2016; 34(3):353-4. PubMed ID: 27514960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
